ARROWHEAD PHARMACEUTICALS, INC. 04280A100 US04280A1007 03/14/2024 Advisory Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES 908474 0 WITHOLD 908474 NONE MERUS N.V. N5749R100 NL0011606264 05/07/2024 Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES 171548 0 WITHOLD 171548 NONE ARVINAS, INC. 04335A105 US04335A1051 05/29/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 234636 0 FOR 234636 FOR REGENXBIO INC. 75901B107 US75901B1070 05/31/2024 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 308973 0 FOR 308973 FOR SUTRO BIOPHARMA, INC. 869367102 US8693671021 06/06/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 987396 0 FOR 987396 FOR BLUEPRINT MEDICINES CORPORATION 09627Y109 US09627Y1091 06/12/2024 Approval of a non-binding advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 3490 0 FOR 3490 FOR BLUEPRINT MEDICINES CORPORATION 09627Y109 US09627Y1091 06/12/2024 Approval of a non-binding advisory vote on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 3490 0 FOR 3490 FOR REPARE THERAPEUTICS INC. 760273102 US7602731025 06/17/2024 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES 394740 0 FOR 394740 FOR KYMERA THERAPEUTICS, INC. 501575104 US5015751044 06/18/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 253428 0 FOR 253428 FOR